Dzhaparidze M N, Naumov A V, Gromova O V, Adamov A K, Eliseev Iu Iu, Kosmoenko O M, Kuz'michenko I A, Kopyrzov V N, Zavorotnykh V I, Zakharova T L, Chekhovskaia G V
Zh Mikrobiol Epidemiol Immunobiol. 1996 Mar-Apr(2):52-5.
Conditions for the submerged cultivation of a strain of V. cholerae O139, were worked out. These conditions ensured a high yield of biomass, soluble O-antigen and exoenzymes (proteinase, phospholipase A) into the culture medium, which exceeded their production by strains of serovar O1, respectively, 2, 3, 4 and 8 times. The preparation, isolated from the culture fluid and lyophilized, contained up to 50% of O-antigen and exoenzymes. In experiments on white mice the preparation exhibited low toxicity (LD50 was equal, on the average, to 1.2 mg) and immunogenicity (ED50 was equal to 3-5 micrograms) with respect to V. cholerae O139, which corresponded to the protective potency of commercial vaccine against V. cholerae O1 infection.
确定了霍乱弧菌O139菌株的深层培养条件。这些条件确保了生物量、可溶性O抗原和胞外酶(蛋白酶、磷脂酶A)在培养基中的高产率,分别比O1血清型菌株的产量高出2、3、4和8倍。从培养液中分离并冻干的制剂含有高达50%的O抗原和胞外酶。在对小白鼠的实验中,该制剂对霍乱弧菌O139表现出低毒性(平均LD50等于1.2毫克)和免疫原性(ED50等于3 - 5微克),这与商业疫苗对霍乱弧菌O1感染的保护效力相当。